India Orthobiologics Market Size, Share, Trends, & Industry Analysis Report: By Application (Spinal Surgery, Trauma Repair, and Reconstructive Surgery), By Product, and By End Use- Market Forecast, 2025-2034

Description

List of Tables

The india orthobiologics market size is expected to reach USD 578.58 million by 2034, according to a new study by Polaris Market Research. The report "India Orthobiologics Market Size, Share, Trends, Industry Analysis Report: By Application (Spinal Surgery, Trauma Repair, and Reconstructive Surgery), Product, and End Use- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The India orthobiologics market encompasses the segment of the healthcare industry focused on utilizing biologically derived materials to aid in the treatment of orthopedic injuries and conditions within the Indian subcontinent. These biological products are designed to promote healing, repair damaged musculoskeletal tissues such as bones, cartilage, tendons, and ligaments, and alleviate pain associated with orthopedic disorders. The field integrates principles of biology and orthopedics to offer innovative treatment options that can potentially enhance patient recovery and improve functional outcomes.

The India orthobiologics market is witnessing significant growth, driven by a confluence of factors, including an aging population, a rising incidence of sports-related injuries and trauma cases, and increasing awareness of advanced treatment modalities. The application in market is rising for various orthobiologic products across different orthopedic procedures, including spinal surgeries, trauma repairs, and reconstructive surgeries. The growing preference for minimally invasive surgeries and the continuous advancements in regenerative medicine are also contributing to the expanding market size and increasing market demand for orthobiologic solutions in India.

India Orthobiologics Market Report Highlights:

By application, the spinal surgery segment currently holds the highest market share in the India orthobiologics market due to the increasing number of spinal procedures addressing various conditions.

By product, the allograft segment presently commands the largest market share in the India orthobiologics market, owing to the widespread use of allografts in bone grafting procedures.

By end use, hospitals currently account for the largest share of the India orthobiologics market, attributed to the high volume of orthopedic surgeries performed in these settings.

The major players active in the India orthobiologics market include DePuy Synthes (Johnson & Johnson), Stryker, Zimmer Biomet, Medtronic, Smith+Nephew, Orthofix Medical Inc., NuVasive, Inc., SeaSpine Holdings Corporation, Integra LifeSciences Holdings Corporation, and Collagen Matrix, Inc.

Polaris Market Research has segmented the India Orthobiologics market report based on application, product, and end use:

By Application Outlook (Revenue - USD Million, 2020-2034)

Spinal Surgery

Trauma Repair

Reconstructive Surgery

By Product Outlook (Revenue - USD Million, 2020-2034)

Demineralized Bone Matrix (DBM)

Allograft

Bone Morphogenetic Protein (BMP)

Viscosupplementation

Synthetic Bone Substitutes

Stem Cell Therapy

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals

Clinics

Product Code: PM5745

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global India Orthobiologics Market Insights

4.1. India Orthobiologics Market - Market Snapshot
4.2. India Orthobiologics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Prevalence of Orthopedic Disorders
  - 4.2.1.2. Growing Number of Road Accidents and Sports-Related Injuries
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of biologic treatments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. India Orthobiologics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global India Orthobiologics Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global India Orthobiologics Market, by Application, 2020-2034 (USD Million)
5.3. Spinal Surgery
- 5.3.1. Global India Orthobiologics Market, by Spinal Surgery, by Region, 2020-2034 (USD Million)
5.4. Trauma Repair
- 5.4.1. Global India Orthobiologics Market, by Trauma Repair, by Region, 2020-2034 (USD Million)
5.5. Reconstructive Surgery
- 5.5.1. Global India Orthobiologics Market, by Reconstructive Surgery, by Region, 2020-2034 (USD Million)

6. Global India Orthobiologics Market, by Product

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global India Orthobiologics Market, by Product, 2020-2034 (USD Million)
6.3. Demineralized Bone Matrix(DBM)
- 6.3.1. Global India Orthobiologics Market, by Demineralized Bone Matrix(DBM), by Region, 2020-2034 (USD Million)
6.4. Allograft
- 6.4.1. Global India Orthobiologics Market, by Allograft, by Region, 2020-2034 (USD Million)
6.5. Bone Morphogenetic Protein (BMP)
- 6.5.1. Global India Orthobiologics Market, by Bone Morphogenetic Protein (BMP), by Region, 2020-2034 (USD Million)
6.6. Viscosupplementation
- 6.6.1. Global India Orthobiologics Market, by Viscosupplementation, by Region, 2020-2034 (USD Million)
6.7. Synthetic Bone Substitutes
- 6.7.1. Global India Orthobiologics Market, by Synthetic Bone Substitutes, by Region, 2020-2034 (USD Million)
6.8. Stem Cell Therapy
- 6.8.1. Global India Orthobiologics Market, by Stem Cell Therapy, by Region, 2020-2034 (USD Million)

7. Global India Orthobiologics Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global India Orthobiologics Market, by End Use, 2020-2034 (USD Million)
7.3. Hospitals
- 7.3.1. Global India Orthobiologics Market, by Hospitals, by Region, 2020-2034 (USD Million)
7.4. Clinics
- 7.4.1. Global India Orthobiologics Market, by Clinics, by Region, 2020-2034 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Collagen Matrix, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. DePuy Synthes (Johnson & Johnson)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Integra LifeSciences Holdings Corporation
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Medtronic
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. NuVasive, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Orthofix Medical Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. SeaSpine Holdings Corporation
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Smith+Nephew
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Stryker
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Zimmer Biomet
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development